InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-33.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Baeuerle Patrick, Autre. Director active across 1 company, notably Cullinan Oncology, Inc.. Cumulatively, 6 disclosures have been published. Activity tracked since 10 August 2021. The latest transaction was filed on 17 February 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
38,500 shares0Common StockSEC:0000899243-23-005731:0
37,500 shares0Common StockSEC:0000899243-22-006419:0
11,000 shares@ US$4.300.0041% mcap24.9% of flowCommon StockSEC:0000899243-21-035415:0
11,000 shares@ US$4.3024.9% of flowCommon StockSEC:0000899243-21-035415
11,000 shares@ US$4.300.0042% mcap25.1% of flowCommon StockSEC:0000899243-21-034306:0
11,000 shares@ US$4.3025.1% of flowCommon StockSEC:0000899243-21-034306
6 of 6 declarations
About Baeuerle Patrick
Baeuerle Patrick is involved with Cullinan Oncology, Inc. His specific role is not detailed, but he contributes to the company's mission in the field of oncology. His expertise and commitment are assets to Cullinan's team, aiming to develop innovative treatments for patients.
